Abstract a-Synuclein (aS) forms round cytoplasmic inclusions in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Evidence suggests a physiological function of aS in vesicle trafficking and release. In contrast to earlier tenets, recent work indicates that aS normally exists in cells in a dynamic equilibrium between monomers and tetramers/multimers. We engineered aS mutants incapable of multimerization, leading to excess monomers at vesicle membranes. By EM, such mutants induced prominent vesicle clustering, leading to round cytoplasmic inclusions. Immunogold labeling revealed abundant aS intimately associated with vesicles of varied size. Fluorescence microscopy with marker proteins showed that the aS-associated vesicles were of diverse endocytic and secretory origin. An aS '3K' mutant (E35K þ E46K þ E61K) that amplifies the PD/DLB-causing E46K mutation induced aS-rich vesicle clusters resembling the vesicle-rich areas of Lewy bodies, supporting pathogenic relevance. Mechanistically, E46K can increase aS vesicle binding via membrane-induced amphipathic helix formation, and '3K' further enhances this effect. Another engineered aS variant added hydrophobicity to the hydrophobic half of aS helices, thereby stabilizing aS-membrane interactions. Importantly, substituting charged for uncharged residues within the hydrophobic half of the stabilized helix not only reversed the strong membrane interaction of the multimer-abolishing aS variant but also restored multimerization and prevented the aberrant vesicle interactions. Thus, reversible aS amphipathic helix formation and dynamic multimerization regulate a normal function of aS at vesicles, and abrogating multimers has pathogenic consequences. † Deceased
Introduction a-Synuclein (aS) is a highly abundant neuronal protein of 140 amino acids. Functions in synaptic vesicle trafficking and fusion have been proposed (1-7) but require further validation. In several neurodegenerative diseases, including Parkinson's Disease (PD) and dementia with Lewy bodies, a portion of aS forms insoluble neuronal aggregates in somata (Lewy bodies) and processes (Lewy neurites), with presynaptic aggregates possibly preceding somatic aggregates (8, 9) . Moreover, genetic evidence supports aS dyshomeostasis as a cause of PD, via missense mutations (10) (11) (12) (13) (14) (15) (16) , copy number variants (17, 18) or upregulated expression (19) .
The longstanding assumption that virtually all physiological aS occurs as a natively unfolded monomer has been challenged in recent years. Unexpected findings from our (20) (21) (22) (23) (24) and other laboratories (6, (25) (26) (27) (28) (29) have shed new light on earlier observations (30) by providing evidence that aS forms physiological, a-helix-rich multimers that are distinct from pathological, bsheet-rich aggregates (the latter are traditionally called aS oligomers). The sizing of such physiological aS multimers may vary from trimers (30) to tetramers (20, 21) to octamers (28) . Our cellpenetrant crosslinking of endogenous aS in intact cells, including primary neurons, trapped abundant aS in $60 kDa species, the size of four monomers (4 Â 14,502 Da ¼ 58,010 Da) (21) . We observed a pronounced sensitivity of this to cell lysis, helping to explain why prior detection of intracellular aS multimers had been elusive. This lability suggested to us that dynamic intracellular populations of metastable aS multimers and monomers co-exist normally (21) , apparently consistent with other recent reports of metastable tetramers (25) , multimers (6, 29, 31) or 'conformers' that may represent multimers (27) .
In response to this new body of work, several labs published data supporting the earlier model of aS existing mainly as natively unfolded monomers (32, 33, 34) . In other labs, the new 'multimer' hypothesis triggered a search for structure-function relationships between aS monomers and multimers, with a special emphasis on their proposed function in vesicle homeostasis. One study (26) found that aS monomers purified from bacteria, but not aS tetramers purified from human red blood cells, confer membrane-remodeling activity in vitro. The authors suggested that tetramers are likely a 'passive' cytoplasmic storage form of the protein. Another group (6) assigned a more active role to the multimers when they used fluorescent protein complementation and high-resolution confocal microscopy to demonstrate that aS multimers on the outside surface of certain vesicles are important for vesicle clustering, which the authors suggested was a means of reducing lateral vesicle diffusion. Another report (28) proposed a physiological function of multimers in SNARE complex formation and vesicle fusion, while other studies implicated vesicle binding in the initial step of aS amyloid formation (35) .
Collectively, these studies suggest complex interrelationships between the normal aS multimer state, membrane binding, vesicle trafficking/fusion and pathological aS aggregation. Using rationally designed aS mutants that decrease multimer formation and increase membrane affinity, we provided evidence that is consistent with this hypothesis. Specifically, we have described aS mutants in which we modified the characteristic KTKEGV motif that is imperfectly repeated six or seven times in aS (23, 24) . Our mutagenesis led to aS proteins whose features differed markedly from those of wt aS. In many iterative experiments, we have found wt aS to be distributed diffusely, enriched in the PBS-soluble cytosolic fraction, and able to be crosslinked into apparent tetramers and related multimers in intact neural cells (21, 23, 24) . In sharp contrast, KTKEGV-motif mutants such as 6 Â KLKEGV (designated 'KLK') or 7 Â KTKEIV ('EIV') accumulate in PBS-insoluble fractions, can no longer be trapped as multimers by intact-cell crosslinking (only monomers are recovered), and form discrete, round cytoplasmic inclusions associated with neurotoxicity (23, 24) . Based on our hypothesis that wt aS is normally in a complex equilibrium that includes cytosolic and membrane-associated monomers and soluble multimers, we now present evidence that our reported KTKEGV mutants may be incapable of undergoing the necessary molecular rearrangements to populate physiologic tetramer/ multimer forms. Instead, these key mutants accumulate at what has often been proposed to be the target membranes of aS: small, highly curved vesicles. Our new findings raise the possibility that normal aS tetramerization/multimerization is required for aS to interact with vesicles only transiently. In contrast, prolonged aS monomer/vesicle interactions result from our multimer-abrogating mutants, thereby inducing abnormal vesicle interactions that have detrimental consequences for neurons.
Results
aS KTKEGV variants that elevate monomer levels rapidly lead to round inclusions in neural cells aS contains six conserved 'KTKEGV' repeat motifs, plus 2-3 less conserved partial repeats (Fig. 1A, upper left panel) . We previously reported (23, 24) that certain mutations introduced into all relevant KTKEGV-like motifs (Fig. 1A , remaining left panels) can markedly change the protein's properties. Specifically, KTKKGV substitutions made in repeats 3, 4 and 5 ('3K'; KTKKGV in just repeat 4 is the fPD mutant E46K), a KLKEGV mutant ('KLK') present in six repeats, and a KLKEIV mutant ('EIV') present in seven repeats) all served to: i) shift the normally highly soluble (cytosolic) aS toward PBS-insoluble fractions (23, 24) ; ii) induce acute cytotoxicity (23, 24) ; iii) lead to round cytoplasmic inclusions (Fig. 1A) ; and iv) prevent aS multimerization, as shown by both fluorescent protein complementation and application of the membrane-permeant crosslinker disuccinimidyl glutarate (DSG) (23, 24) . A neutral variant KTKEGR ('EGR') in six repeats behaved similarly to wt aS: it was PBS-soluble, diffusely cytoplasmic, non-toxic and allowed both YFP complementation and DSG crosslinking at 60, 80 and 100 kDa multimer positions (23, 24) .
Based on these findings, we now sought to characterize further the inclusions formed by the aS variants and how they might be related to those other properties: lack of multimerization, reduced solubility and increased neurotoxicity. In order to generate stable reporter cell lines to quantify inclusion formation, we expressed aS C-terminal Venus-YFP fusion proteins of the above-mentioned wt, 3K, KLK, EIV and EGR mutants in M17D human neuroblastoma cells. We generated stable cell pools by Zeocin selection. Consistent with our prior results (23, 24) , we observed invariant inclusion formation by 3K, KLK and EIV aS, but not by wt or EGR (Fig. 1A , middle panels: 5 days after transfection). The long-term maintenance of stable 3K, KLK or EIV lines, however, was not possible, as these three mutant lines lost expression over time (Fig. 1A, right panels) , presumably due to a selection advantage of cells expressing low levels of these mutants. In contrast, the wt and benign EGR mutant cells were not lost (Fig. 1A , right panels).
To further characterize these potentially cytotoxic (23, 24) inclusions, we mainly focused on the 3K and KLK mutants. Both aS variants were confirmed to be largely monomeric by intactcell crosslinking with 1 mM DSG of the M17D transfectants followed by Western blot (WB) with different antibodies (Fig. 1B) , as expected from our prior work (23, 24) . For aS 3K (Fig. 1B , left half), only small amounts were trapped by DSG at the putative tetramer (60 kDa, called aS60) and dimer (30 kDa, called aS30) positions. For aS KLK (Fig. 1B, right half) , aS60 was entirely abolished; only trace amounts of dimer (aS30) in addition to , and wt vs. KLK aS were transiently expressed in M17D cells for 48 h followed by DSG intact-cell crosslinking and Western blot (WB). As a control, mock-transfected cells (-) are shown. Two different DNA amounts (4 and 8 mg per 6-cm dish, respectively) were transfected in the case of wt vs. 3K (left panels), total protein lysate and blots were developed for aS (mAb Syn-1), DJ-1 (dimeric protein, positive control/loading control) and Ran (monomeric protein, negative control/loading control). Wt vs. KLK (right panels, mAb 15G7) was analyzed by sequential extraction (PBS fraction, $cytosol; TX-100 fraction) and adding DSP/bME-reversed crosslinking (see Methods) to visualize total aS amounts. Note that, consistent with earlier data, we sometimes observe aS30 puta- abundant monomers (aS14) were present. The wt aS transfectants contained abundant aS multimers at aS60 (putative tetramer), aS80 (80 kDa) and aS100 (100 kDa) positions. We have hypothesized that aS80 and aS100 represent hexamers and octamers or alternatively are distinct native tetramer conformations that are trapped slightly differently by the DSG (i.e. they are conformers) (21) . In addition, wt aS populated some putative dimers (aS30). We previously documented that the dimers are almost absent with endogenous wt aS but occur to a variable degree with overexpressed wt aS (see, e.g. Fig. 3A in (21) ). We previously excluded that the species described here are aS heteromultimers with other aS-binding proteins by using co-IP, 2D gel electrophoresis (21) and mass spectrometry (23) . The current data thus support that wt aS forms abundant multimers, principally tetramers, in intact neural cells, whereas the aS 3K and KLK mutants populate overwhelmingly monomeric species. This apparent stabilization of aS in a monomeric state promised to be of value in our quest to explore aS structure-function (and dysfunction) relationships.
To overcome the loss of 3K and KLK expressing cells over time, we isolated the doxycycline (dox)-inducible clonal lines M17D-TR/aS-wt::YFP, M17D-TR/aS-3K::YFP and M17D-TR/aS-KLK::YFP, and collected fluorescent images over an induction time course. Only very few inclusions, which were small and not bright, developed in the control M17D-TR/aS-wt::YFP cells (Fig. 1C) . For 3K and KLK, diffuse YFP signal became visible as soon as 6 h after dox-induction, and initial inclusions appeared as soon as 12 h post-dox ( Fig. 1D and E) . We categorized inclusions into three size groups (<1, 1-2 and >2 mm in diameter) and observed a trend of increasing inclusion size and decreasing inclusion number between 12 and 72 h, suggestive of fusion events over time ( Fig. 1D and E) . A portion of the 3K, and even some of the KLK, signal remained diffusely cytosolic ( Fig. 1D and E), like almost all the wt signal (Fig. 1C) .
The aS cellular inclusions are rich in vesicles
To further analyze the inclusions caused by 3K and KLK expression, we induced M17D-TR/aS-3K::YFP cells for at least 24 h and imaged them by immuno-electron microscopy (EM). In the analyzed cells, we observed round zones in the cytoplasm ( Fig. 2A , middle panel, boxed) that were more electron-dense than the surrounding cytoplasm and had the approximate diameters of the large YFP inclusions seen by light microscopy in living cells ( Fig. 2A, top panel) . Immunogold labeling for YFP ( Fig. 2A , black dots in middle and bottom panels) confirmed that these structures were rich in aS-3K::YFP, and higher magnification ( Fig. 2A , bottom right panel) identified vesicular (arrowheads) and tubular (arrows) membranous structures as principal components. In the absence of dox-induction (Fig. 2B) , no inclusions were seen by either fluorescence microscopy or EM, and immunogold labeling was virtually absent. Immunogold labeling of the induced cells for aS (pAb C20; Fig. 2C ) confirmed the colocalization of multiple vesicles (arrowheads), tubules (arrows) and aS (black dots) within the spherical inclusions. Stronger image contrasting in the absence of immunogold (Fig. 2D ) allowed even better visualization of myriad round vesicles (arrowheads) and elongated tubules (arrows) within the cytoplasmic inclusions. Another consistent finding in many but not all cells analyzed were large vacuoles with an electron-lucent center and a $0.5-2 mm in diameter in close proximity to the inclusions (asterisks in Fig. 2A, C and D) . Their size and appearance (the jagged perimeters are likely an artifact of fixation) are consistent with lipid droplets.
As a control, dox induction of wt aS::YFP (i.e. in M17D-TR/aSwt::YFP cells) produced only diffuse cytoplasmic YFP signals (Fig. 3A, top panel) , consistent with diffuse immunogold labeling for YFP (middle panel) or aS (pAb C20, bottom panel). In contrast, the multimer-abolishing variants aS EIV ( Fig. 3B ; see Fig.  1A for its sequence) and aS KLK (Fig. 3C ) had YFPþ and aSþ inclusions (note that EIV was studied in epon sections, KLK in frozen sections). Interestingly, we observed a variety of different membranous structures in the inclusions, ranging from clusters of vesicles of different diameters (e.g. EIV: Fig. 3B middle panel) to pronounced tubular structures (e.g. EIV: Fig. 3B bottom  panel) , and these could co-exist in the same cells. Moreover, the consistent position of the immunogold particles relative to the vesicles (e.g. EIV: Fig. 3B middle panel) suggested that aS is localized on but not inside vesicles.
aS-rich inclusions contain vesicles of diverse origins
To identify the origin of the vesicles that cluster with the multimer-abolishing aS variants, we transfected the 3K::YFP and KLK::YFP inducible lines with various constitutively expressed marker proteins that were tagged with red fluorescent protein (RFP). As a first step, we transfected RFP alone into M17D parental cells as well as into the inducible lines aS wt::YFP, 3K::YFP and KLK::YFP ( Fig. 4A ) and waited for stable RFP cDNA integration in the cell pool. After inducing the aS transgenes, we observed diffuse co-localization of wt aS with RFP, as expected. The inclusions that were invariably formed in the case of 3K and KLK, however, did not trigger analogous local accumulations of the RFP protein; it remained diffuse (Fig. 4A) . Next, we co-expressed a variety of RFP-tagged membrane marker proteins together with aS 3K::YFP (Fig. 4B ) or KLK::YFP (data not shown). To better model the steady-state situation, we again waited for stable integration of these transgenes to occur and examined a pool with a relatively low percentage of doublepositive cells. In 'blinded' cultures, we identified those cells that had inclusions and were clearly both YFP-and RFP-positive. Next, we asked whether the aS::YFP inclusions in such doublepositive cells were themselves also RFP-positive. We observed at least one such double-positive inclusion in 100% of inclusionbearing cells co-expressing the RFP-tagged endosomal markers transferrin receptor, RHOB (Ras homology family member B), Rab5, Rab7 and Rab11 ( Fig. 4B ; see legend for further details). The autophagosomal marker Lamp1 (91.7 6 7.2% doublepositive cells with punctate colocalization) and the Golgi marker sialyltransferase (SiT; 87.5 6 10.2%) co-localized with the aS-rich inclusions, as well (Fig. 4B ). In contrast, the signals from RFPlabeled ER (Calreticulin, Crt; 8.3 6 7.2%) or mitochondrial (cytochrome c oxidase subunit 8A, COX8A; 4.2 6 7.2%) markers spared the areas of aS inclusions, just like RFP alone (4.2 6 7.2%). Based on this observation, we reasoned that pharmacological inhibition of pathways that produce cellular vesicles may reduce the inclusion formation. We thus treated the cell line M17D-TR/aS-3K::YFP//RFP (which also stably expressed RFP for normalization) with DMSO vehicle only, or the endocytosis inhibitor dynasore, or brefeldin A, which inhibits vesicle transport from ER to Golgi. IncuCyte-based automated image analysis of YFP (only punctate signals taken into account) and RFP (pan-cellular signal) revealed that both drugs modestly but significantly reduced inclusion formation ( Fig. 4C : see bar graphs and legend for quantification). In contrast to our transient transfections (23, 24) , the cultures exhibited only minor acute toxicity when aS expression was induced in the aS 3K or aS KLK inducible lines (not shown). In this context, we observed that the 3K::YFP and KLK::YFP expressing M17D cells were still able to undergo mitosis, during which the inclusions were still present in daughter cells but visibly rearranged ( Fig. 4D and E). To validate the above findings in the absence of fluorescent protein tags, we generated inducible cell lines for untagged aS wt (M17D-TR/aS-wt) and aS KLK (M17D-TR/aS-KLK). WB confirmed the induction of transgene expression only in the presence of dox (Fig. 5A ). Immunofluorescence (IF) using antibodies specific for aS (pAb C20) and transferrin receptor revealed strong co-localization of aS KLK, but not aS wt, with putative endosomal vesicles containing transferrin receptor (Fig. 5B ). This was confirmed for KLK aS (Fig. 5C , right panel) but not for wt aS (left panel) by performing co-fractionation with transferrin receptor by nondenaturing size-exclusion chromatography. In this experiment, the cell lysates were prepared from the induced lines by passing through a 16G needle 20 times and in the absence of detergent in order to leave most vesicles intact. Subsequent IF microscopy of the aS KLK line revealed pronounced co-localization with a variety of other vesicular markers (Fig. 5D) , from left to right: Rab5 (early endosome), Rab7 (late endosome), Rab11 (recycling endosome), Lamp1 (lysosomal/autophagosomal) and Giantin (Golgi). In contrast, we did not observe major overlap with ER membranes (marked by Calnexin: Fig. 5D , third panel from right) or mitochondria (TOM20: second panel from right). In agreement, iodixanol gradients of total protein lysates separated aS KLK protein (Fig. 5E , right panel) from the dense ER membranes (marker: calnexin). Conversely, aS KLK cofractionated with the vesicular markers transferrin receptor and Lamp1. As expected, wt aS (Fig. 5E , left panel) mainly cofractionated with GAPDH in the top (cytosolic) fractions of the iodixanol gradient.
3K and KLK aS proteins accumulate at synaptic vesicles in neurons
Similar to M17D human neuroblastoma cells, lipofection of 3K::YFP into primary neurons time-dependently induced round, punctate inclusions (Fig. 6A , lower panels, arrows indicate puncta) in somata and neurites that increased in size over time, whereas wt aS remained diffuse or else small, focal accumulations were mostly transient and disappeared (Fig. 6A , upper panels). Around 48 h post-transfection, the occurrence of cells with defined round somatic or neuritic inclusions was strongly increased (Fig. 6A , quantification on the right) for 3K (75.3 6 4.5% of cells) compared to wt (6.7 6 0.7% of cells). This focal accumulation of 3K aS was often accompanied by evidence of gradual cytotoxity such as rounded cell bodies seen by 60 h (Fig. 6A, arrowhead) . Interestingly, we observed that aS-3K::YFP accumulations were apparently able to 'seed' the accumulation of cotransfected aS-wt::RFP into the focal puncta (Fig. 6B , fourth column), whereas this co-localization did not occur with cotransfected RFP alone (Fig. 6B, third panel) . This coaccumulation phenomenon was seen in both somata (arrows) and neurites (arrowheads) (Fig. 6B , fourth panel; magnified in fifth panel). In the same experiments, aS-wt::YFP and RFP (Fig.  6B, first panel) or aS-wt::YFP and aS-wt::RFP (Fig. 6B , second panel) just co-localized diffusely throughout the cytoplasm.
Importantly, in the absence of fluorescent protein tags, IF of untagged aS 3K and KLK expressed in primary mouse neurons also showed punctate inclusions (Fig. 6C , middle and bottom row, left panel) whereas aS wt expression remained diffuse (Fig. 6C , top row, left panel). Consistent with the vesicular localization of 3K and KLK in the neuroblastoma lines, we found strong colocalization in the primary neurons of both mutant aS forms with the synaptic vesicle marker synaptophysin, while such punctate co-localization was less pronounced for wt (Fig. 6C) . These observations were then corroborated by IF and parallel immunogold-EM analysis of lentivirus-transduced primary mouse neurons (infection on DIV7, fixation on DIV14; Fig. 6D ): transduced aS wt (Fig.  6D , top right panel) was found in both vesicle-rich areas (arrows in EM images) and other parts of neurites (arrowheads in EM images), whereas aS 3K (Fig. 6D , bottom left panel) and KLK (bottom right) were almost exclusively associated with vesicles, apparently in boutons. Empty-vector treated neurons (Fig. 6D, top left  panel) showed only a few, scattered gold particles, confirming that most of the observed aS gold signals in the transduced neurons were indeed due to expression of the transgene. Quantification of gold particles as vesicle-associated vs. 'free' confirmed a significant redistribution to vesicles for aS 3K and KLK vs. wt ( Fig. 6E and F) . Of note, the endogenous mouse aS exhibited a similar diffuse staining as transduced wt human aS. Similar to results in the neuroblastoma cells, this non-transient expression of each of the aS variants was not accompanied by an obvious time-dependent neuronal loss. To search for subtler effects of the aS variants, we monitored neurite outgrowth by unbiased automated quantification (IncuCyte) in the transduced mouse neurons and observed a significant $20% reduction in neurite length for aS 3K (80.8 6 13.6% of wt neuron length) and KLK (81.7 6 11.2% of wt neuron length) 96 h post-transduction of DIV2 neurons ( Molecular mechanism: abnormally stabilized aS amphipathic helices underlie the strong aS-membrane interactions and aberrant vesicle interactions of the multimer-abrogating mutants Based on a helical wheel model of aS amphipathic helix formation in vitro (e.g. Fig. 1 of (5)), we hypothesized that our inclusion-promoting aS variants (3K, KLK, EIV) abnormally stabilize a-helical aS monomers at membranes (see Fig. 7 for model). It is believed that the 11-residue repeats having the core motif KTKEGV enable aS to transiently and dynamically interact with the outer surface of curved membranes (5) . Especially when lipid packing defects occur in such membranes, aS binding was reported to induce an amphipathic helix whose hydrophobic half is buried in the outer leaflet of the lipid bilayer (36) (37) (38) , while the hydrophilic half is exposed to the aqueous environment of the cytoplasm.
In addition, positively-charged lysine residues on the hydrophilic face of each repeat motif helix are believed to interact with negatively charged lipid headgroups of vesicles (39) . Due to the occurrence of several polar (threonine) or small (glycine) residues in the hydrophobic half of each repeat motif, the hydrophobic interactions between wt aS and the lipid bilayer can be considered relatively weak (Fig. 7A) . This may explain why wt aS is largely a soluble, cytosolic protein, with only 10-20% of it associated with membranes (40, 41) . Our strongly inclusionpromoting aS repeat mutants KLK and EIV have increased hydrophobicity in the hydrophobic half of the helix (Fig. 7C and D) . This would lead to a more energetically stable amphipathic helix and thus account for an enhanced binding to cytoplasmic vesicles, consistent with the increased occurrence of aS EIV and KLK in buffer-insoluble fractions of sequential extracts that we observe (24) . For aS 3K (Fig. 7B) , this enhanced membrane interaction (23) may be due to the additional positive charges in the hydrophilic half of the helix, which can interact with negatively charged lipid headgroups, as has been reported for the E46K fPD mutation alone (42) .
Based on the above considerations, we reasoned that weakening the membrane-induced aS amphipathic helices in our mutants might reverse the observed effects of 3K, KLK and EIV aS. To this end, we introduced additional energetically unfavorable arginines (positive charges) into the hydrophobic half of the abnormally stabilized aS KLK amphipathic helix, generating a compound mutant with the consensus sequence KLKEGR (Fig. 8A-C,  bottom) . Strikingly, this variant reversed the strong membrane association of aS KLK (Fig. 8D, middle) : KLKEGR showed a strong cytosolic enrichment (Fig. 8D, bottom) , similar to wt (Fig. 8D, top) . Importantly, this restored solubility was accompanied by restored aS60/80/100 multimer formation, as tested by crosslinking (Fig. 8E, bottom, vs . the mostly monomeric KLK) and a restored diffuse cytosolic distribution upon expression in rodent neurons (Fig. 8F, bottom, vs . the focal accumulation of KLK).
Discussion
aS is the principal misfolded protein that accumulates progressively in a group of fatal neurodegenerative diseases, including PD, dementia with Lewy bodies, multiple system atrophy, and to a lesser degree in Alzheimer's disease. Accordingly, it is critical to understand the mechanisms that initiate aS accumulation in round insoluble cytoplasmic Criteria for significance: *P < 0.05, ****P < 0.01, ***P < 0.001, ****P < 0.0001. inclusions in these disorders and to establish controlled experimental systems to model this process, in order to screen for compounds that could restore normal aS homeostasis. To these ends, we report detailed analyses of a new model for the controlled formation of round cytoplasmic aS inclusions associated with neurotoxicity. In our initial work on this model (24), we engineered certain KTKEGV repeat-motif mutations that abolished the abundant $60 kDa assemblies we normally observed with wt aS upon intact-cell crosslinking. We reported that the loss of the 60 kDa assembly caused by these aS mutations was accompanied by neurotoxicity, and the resultant aS proteins were largely insoluble and led to multiple, round cytoplasmic inclusions. In the current study, we analyze two such repeat-motif mutants in depth in order to systematically characterize the striking inclusions they form: a) aS 3K (E35K þ E46K þ E61K) that represents an amplification of the fPD-linked mutant E46K into the two adjacent KTKEGV motifs; and b) an engineered mutant that changes the KTKEGV core motif to KLKEGV in six repeats.
By studying both variants in several neuronal systems, we show that the round cytoplasmic inclusions arising from these KTKEGV motif mutations are comprised of clusters of vesicles and tubules intimately associated with the focal accumulation of aS (see the immunogold EMs of Figs 2, 3 and 6). Dense clusters of vesicles shown to be derived from diverse subcellular membranes (endocytic, lysosomal, Golgi) developed in the cytoplasm of human neural cells upon expression of aS 3K or KLK (Figs 4  and 5 ). Based on a previous study that analyzed a KLK-like aS variant in vitro and in yeast (43), we expected our aS variants to potentially interact with membranes besides those of small vesicles, but we found no evidence for appreciable interactions with non-vesicle membranes such as mitochondria and ER. Cytotoxicity, which is typically pronounced when we express mutants like 3K and KLK transiently at high concentrations (23, 24) (Fig. 1A) , was less severe when the expression was stable and chronic, perhaps due to lower expression levels, the absence of lipofection, and/or compensatory cellular mechanisms developing over time. Nonetheless, we were unable to generate stably expressing aS 3K or KLK neuroblastoma cells, and we observed reduced overall neurite length in transduced neuronal cultures expressing the 3K or KLK mutants for several days ( Fig. 6G and H) . These results suggest that the accumulation of multimer-abrogating KTKEGV motif mutants interferes with vital cellular processes. The vesicle clusters that we observe are reminiscent of the effects of expressing human aS at relatively high concentrations in S. cerevisiae. After these aS inclusions in yeast had initially been interpreted by light microscopy as proteinaceous aggregates, Soper et al. instead provided ultrastructural evidence that aS accumulations in yeast were not comprised of fibrils but rather were clusters of many vesicles (44) . Similarly, Gitler et al. observed in yeast the accumulation of undocked vesicles coalescing into massive intracellular vesicular clusters in a wt aS dose-dependent manner (45) . By IF and immuno-EM, these yeast inclusions were associated both with aS and vesicle markers of diverse subcellular origin (endosomes, Golgi, lysosomes), closely similar to the marker co-localization data in our 3K and KLK aS transfectants (Figs 4 and 5) . In contrast to yeast expressing wt human aS, mammalian cells expressing very high levels of wt or even fPD single-mutant aS (e.g. E46K) still have the protein in a highly soluble state, without discrete inclusion formation (23, 24, 46, 47) . Our new data herein indicate that the strong vesicle-aggregating property of human aS is not unique to yeast but can also be achieved in mammalian neurons if the aS sequence is altered in ways that move the tetramer/multimer-to-monomer equilibrium strongly toward excess monomers. As far as aS physiology is concerned, the trafficking and clustering of vesicles within synaptic terminals has been suggested to be a normal function of aS (1-7) . This raises the possibility that the abnormal vesicle clustering we find to be caused by KTKEGV mutants is a form of excessive aS function. Importantly, the inclusion propensity of wt aS is not zero (Fig. 1C) , indicating that our aS mutants may augment an intrinsic feature of the wt protein. In this scenario, aS 3K and aS KLK can be considered dominant active (or constitutively active) proteins. Interestingly, a study (26) reported the membrane-remodeling activity of membrane-associated monomeric aS, and the authors suggested that aS tetramers in the cytosol (which they successfully prepared from fresh erythrocytes) was not active in their assay and thus might represent an "inactive storage form" of the protein. We identified the KLK, 3K, EIV and EGW repeat-motif mutations because of their inability to form and maintain cytosolic aS tetramers/multimers (23, 24) . non-transduced neurons, which was set to 1. Three independent experiments were done in duplicates (N ¼ 3, n ¼ 6). Significance aS 3K and KLK relative to aS wt-transduced neurons. One-way ANOVA for all statistical analyses, except 6(A) (unpaired t-test, two-tailed). Means þ/À S.D. Criteria for significance: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Taken together, these various considerations support a hypothetical model (Fig. 9 ) in which wt aS is translated on the ribosome as an unfolded monomer (A) that then rapidly binds to the external surfaces of certain curved vesicle membranes in the crowded cytoplasm and adopts helical folding (B1), thereby promoting vesicle clustering to a limited extent. The aS-vesicle interactions could weaken when aS monomers normally multimerize (B2), as we recover multimers overwhelmingly from the cytosol (21, 23) . Metastable soluble multimers are likely to disassemble in the cytosol over time (B3), starting a new dynamic cycle (B1'-B3'). For our KTKEGV mutants 3K, KLK and EIV (C1-C4), this cycle could be impaired: after translation and membrane binding (C1), they are presumably unable to undergo normal multimerization, prolonging their membrane association as monomers and intensifying the vesicle-clustering effect (C2). The acute/subacute consequences may be defects in vesicle trafficking and membrane rearrangements such as the tubulation we observe (C3). A longerterm consequence may well be the coming together of the excess monomers to form b-sheet-rich aS aggregates (C4; see next paragraph). Excess wt aS monomers (D1-D4) as caused by SNCA gene duplication/triplication may result in similar defects due to shifting the normal tetramer:monomer equilibrium toward free monomers by titrating out a limiting factor (e.g. arachidonic acid or another small lipid (29) ) that helps assemble and transiently stabilize multimers (D2).
In this combined model, physiological aS tetramers/multimers could serve the purpose of a) limiting aS monomer functional activity at membranes; and b) storing aS in a nonaggregation-prone form (20) in the cytoplasm. Further studies will be necessary to elucidate how aS switches between monomeric vs. multimeric and between cytosolic vs. membranebound states and how this dynamic behavior regulates normal aS function in vesicle trafficking/fusion. The mutants that we describe should be valuable tools, as they can be considered loss-of-function for normal aS multimerization, and the resultant excess monomers may be dominant-active with regard to aS function at vesicles. If the apparent monomeric nature of our aS variants in the inclusions is established, the question will be whether vesicle clustering is achieved in the absence of direct aS-aS interactions. An answer could be a 'double anchor' mechanism where one synuclein molecule can interact with two different vesicles, as was recently proposed (48) . Several such connections via aS monomers could lead to larger vesicle clusters and, ultimately, to remodeling of the vesicles within the clusters (e.g. the tubulation seen by EM in Fig. 2 ). Some aS monomers stabilized at membranes may still be able to multimerize at least transiently, consistent with models of membraneassociated multimer formation that have been proposed by the Roy (6) and Sü dhof (28, 49) labs.
With respect to aS pathology, we have so far not detected amyloid fibrils in our inclusions: EM images gave no indications of clear-cut, b-sheet-rich amyloid fibrils (Figs 2, 3 and 6D) . However, early EM characterization of Lewy bodies showed the presence of many vesicles in the periphery of granular Lewy bodies (Fig. 4 in (50) ) and Lewy body-related swellings (Figs 5 and 6 in (50)). Similar phenomena were described by other researchers (51,52) and numerous cored vesicles but few Lewy body filaments were found in an autopsy case of juvenile parkinsonism (53) . Moreover, an association of synaptic proteins and LBs was described (54) . These findings raise the possibility that the abnormal vesicle clusters we observe consistently in our tetramer-abrogating mutants are an early pathogenic step toward Lewy-type aggregates. Although membrane association has often been considered a physiological feature of aS biology (55, 49) and has been associated with decreased amyloid fibril formation (56) , it has also been reported to trigger pathological aggregation under certain conditions, apparently due to increased local aS concentration on membranes (35) . In theory, the intimate association of aS with vesicles that we see in our acute inclusions could dissociate over longer times, leading to a core of abnormal aS fibrils and clusters of vesicles nearby in the periphery (Fig. 9C3 and 4) . Moreover, our current data cannot Figure 7 . Wt aS forms a normally dynamic membrane-induced amphipathic a-helix. (A) Top: wt aS contains at least seven 11-residue repeats (1-5 and 7 being highly conserved) arranged in a helical wheel (a 3-11 helix: 3 turns over eleven residues). Blue indicates basic (light blue: histidine), red: acidic, purple: polar uncharged, and black: non-polar residues. Bottom: Schematic of aS repeat #4 embedded in the outer leaflet of a curved vesicle membrane (lipid head-groups in red, fatty acid 'tails' in black). Hydrophobic interactions between non-polar residues and the lipid environment as well as electrostatic interactions between positively charged lysine-residues (blue) and negatively charged lipid headgroups (red) are proposed to stabilize the amphipathic helix transiently. (B-D) Analogous to (A), but for 3K, KLK and EIV aS. Note that KLK has a distal T92L mutation that is not depicted here (see Fig. 1A ). Orange lines illustrate increased aS-membrane attraction.
rule out the possibility that the 3K and KLK mutations directly affect the tertiary structure of aS or that pathological oligomers and protofibrils may be present that are not readily resolved by immuno-EM. In this regard, certain engineered E!K aS mutations (E57K and E35K) expressed in a rat lentivirus model have been reported to inhibit fibril formation but stabilize pathologic oligomers (57), leading to dopaminergic loss in the substantia nigra. aS variants that formed mature amyloid fibrils very quickly were less toxic, and the authors speculated that abnormal aS oligomers might interact with and potentially disrupt membranes.
Lastly, very subtle changes in aS homeostasis (likely not yet accompanied by major misfolding events) can impair vesicle trafficking/function that then contributes to decreased cell viability, as observed in patient-derived neurons (58) . It would be surprising if the multiple aS-positive vesicle clusters we describe in neural cells (Figs 1-5) , in which vesicles derived from some but not all types of subcellular compartments aggregate and can no longer achieve their correct distributions, did not negatively affect the cells. It should be noted, however, that we cannot rule out that the excess binding of aS to vesicle membranes alone, even in the absence of aberrant clustering, is sufficient to impair vesicle trafficking, e.g. by stabilizing vesicle curvature and thereby preventing proper fusion with target membranes. In mature neurons in vivo, where much of aS is localized to synapses, an abnormal excess of monomers bound to synaptic vesicles (as seen in Fig. 6 ) could cause both subacute (Fig. 6A) and chronic ( Fig. 6G and H) neurotoxicity. Based on the relatively subtle toxicity of prolonged overexpression in neurons (Fig. 6) , we speculate that rodents expressing 3K or KLK aS could be viable but abnormal and serve as useful in vivo models to study the effects of chronic aS monomer-mediated vesicular clustering, as seen here in mammalian neural cells and previously in yeast (44, 45) . Such novel chronic models could also contribute to bridging two aspects of aS dyshomeostasis: impaired vesicle trafficking and Lewy-type aS aggregates.
Materials and Methods
All materials mentioned were purchased from Invitrogen unless stated otherwise.
Animal samples
Rodent samples were acquired under protocol number 05022 ('Mouse Models for Parkinson's Disease'), approved by the appropriate IACUC, the Harvard Medical Area Standing Committee (24) and pCAX/dsRed (23) have been described. aS-KLKEGR was synthesized as a GeneArt String DNA fragment (GeneArt/Life Technologies) and inserted into pcDNA4/TO/myc-His A (pcDNA4) with the In-Fusion HD Cloning Kit (Clontech). Plasmids mCherry-Rab5a-7 (Addgene plasmid # 55126), mCherry-Rab5a-7 (Addgene plasmid # 55127) mCherry-Rab11a-7 (Addgene plasmid # 55124), mCherry-SiT-N-15 (Addgene plasmid # 55133), mCherry-TFR-20 (Addgene plasmid # 55144), mCherry-ER-3 (Calreticulin; Addgene plasmid # 55041), mCherry-Endo-14 (RHOB; Addgene plasmid # 55040), mCherry-mito-7 (COX8A; Addgene plasmid # 55102), and mCherry-lysosomes-20 (LAMP1; Addgene plasmid # 55073) were kind gifts from Michael Davidson. pLVX-EF1a-IRES-mCherry vector was purchased from Clontech and viral constructs pLVX-IRES-mCherry/aS-wt, pLVX-IRES-mCherry/aS-3K and pLVX-IRES-mCherry/aS-KLK were generated by ligating SpeI/NotI digested PCR product into respective sites of pLVX-EF1a-IRESmCherry. Previously described cDNA constructs (23, 24) were used as templates for PCR amplification. 
Production of lentiviral particles

Intact-cell crosslinking
Cells were collected by trituration, washed with PBS, and resuspended in PBS with Complete Protease Inhibitor, EDTA-free (Roche Applied Science). Crosslinkers DSG and DSP were prepared at 50 mM final concentration in DMSO immediately before use. Samples were incubated with crosslinker for 30 min at 37 C with rotation. The reaction was quenched by adding Tris, pH 7.6, at 50 mM final concentration and incubated for 15 min at RT. After quenching, proteins were extracted (see below). DSG crosslinking occurred at 1 mM final concentration. 1.5 mM DSP-crosslinked samples underwent reductive cleavage by adding 5% (final concentration; w/v) bME to the sample buffer before boiling to maximize aS immunoblot detection by avoiding washing-off effects (22) .
Protein extraction
To generate total protein extracts (cytosolic and membrane proteins), cells were lysed in 1% Triton-X 100 detergent (Sigma) by vortexing and incubation on ice for 20 min. Samples were then ultracentrifuged at 100,000g for 60 min at 4 C to collect the supernatant. For sequential extraction, cells were lysed by sonication and centrifuged at 100,000g for 60 min, and the supernatant was collected (PBS cytosolic fraction). The pellet was solubilized in PBS/PI with 1% TX-100 and again centrifuged at 100,000g for 60 min. The resulting supernatant was collected (TX fraction: membrane proteins). 
Cell culture and transfection
Cells were cultured at 37 C in 5% CO 2 . Human neuroblastoma cells (BE (2)-M17, called M17D; ATCC number CRL-2267) were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 50 units per ml penicillin, 50 mg per ml streptomycin, and 2 mM L-glutamine. 293T cells used for lentiviral production (ATCC number CRL-3216) were cultured in DMEM supplemented with 10% FBS. Primary mouse neurons were cultured from CD-1 mice (Charles River, Wilmington, MA) as described (23) . Cells were transfected using Lipofectamine 2000 (unsupplemented neurobasal medium instead of Opti-MEM for primary neurons) or transduced.
Stable cell pools and cell lines
Tet-on lines M17D-TR/aS-wt::YFP, M17D-TR/aS-3K::YFP, M17D-TR/aS-KLK::YFP were generated by Lipofectamine 2000 cotransfecting pcDNA6/TR and described plasmids pcDNA4/aSwt::YFP, pcDNA4/aS-3K::YFP (23) and pcDNA4/aS-KLK::YFP (24), followed by Blasticidin (1 mg per mL) and Zeocin (200 ng per mL) selection. Expression was induced by adding 1 mg per ml (f.c.) dox to culture media. Lentivirally transduced pools were generated by infecting cells with titred virus at appropriate ratios. pcDNA4/aS-3K::YFP//RFP lines were generated by transducing pcDNA4/aS3K-wt::YFP with pLVX-IRES-mCherry (empty vector) viral particles.
Subcellular fractionation and gel filtration
1% TX-100 total protein lysates were loaded onto a 2.5-30% discontinuous Optiprep (Sigma) gradient, and run for 2.5 h at 200,000g. 1-ml fractions were collected, and 25-ll aliquots loaded onto an SDS gel. Size-exclusion chromatography (Superdex 200) was carried out as described (20) .
Immunocytochemistry
Cells were grown on poly-D-lysine-coated surfaces, rinsed twice with HBSS with divalent cations, fixed 25 min at RT with 4% paraformaldehyde/PBS, then washed three times for 5 min with PBS. Cells were then blocked and permeabilized with 5% BSA/ 0.25% Triton X-100/PBS. Cells were incubated with primary antibody in block-permeabilizing buffer for 2 h at RT or overnight at 4 C. After incubation with primary antibody, cells were washed
Fluorescence microscopy
Fluorescence microscopy of cells in culture dishes was done on an AxioVert 200 microscope (AxioCam MRm camera; AxioVision Release 4.8.2; all by Zeiss, Jena, Germany). Images of YFP were collected using a GFP/FITC filter cube and are pseudo-colored green. Confocal images were obtained on a Zeiss LSM710 system. 
Live-cell imaging
Electron microscopy
Cells were fixed in 2.5% glutaraldehyde, 1.25% paraformaldehyde, 0.03% picric acid in 0.1 M sodium cacodylate buffer (pH 7.4) for 1 h, washed 3x in 0.1M Cacodylate buffer, then postfixed in 1% Osmium tetroxide (OsO4)/1.5% Potassiumferrocyanide (KFeCN 6 ) for 30 min, washed in water 3x and incubated in 1% aqueous uranyl acetate for 30 min followed by two washes in water and subsequent dehydration in grades of alcohol (5 min each; 50%, 70%, 95%, 2x 100%). Cells were embedded in TAAB Epon (Marivac Canada Inc. St. Laurent, Canada) and polymerized at 60 C for 48 h. Ultra-thin sections (about 80 nm) were cut on a Reichert Ultracut-S microtome and picked up on to copper grids. For immunogold labeling, the sections were etched using a saturated solution of sodium metaperiodate in water for 5 min at RT. Grids were then washed 3x in water and floated on 0.1% Triton-X-100 for 5 min at RT. Blocking was carried out using 1% BSA þ 0.1% TX-100/PBS for an hour at RT. Grids were incubated with pAb C20 or anti-GFP antibody (1:50, Abcam 6556) in 1% BSA þ 0.1% TX-100/PBS overnight at 4 C. Grids were washed three times in PBS to remove unbound GFP antibody followed by incubation with 15nm Protein A-gold particles (Department of cell biology, University Medical Center Utrecht, the Netherlands) for an hour at RT. Grids were washed with PBS and water, stained with lead citrate and examined in a JEOL 1200EX Transmission electron microscope (JEOL USA Inc. Peabody, MA, USA) and images were recorded with an AMT 2k CCD camera.
Statistical analyses
Blinded analyses were performed by assigning random numbers to dishes or images by one investigator before representative images were taken or features were counted by another investigator. We performed one-way ANOVA including Tukey's (Figs 4C, 6E, F and H) or Dunnett's ( Fig. 4B ) multiple comparisons test as well as unpaired, two-tailed t-test (Fig. 6A) analyses using GraphPad Prism Version 7 following the program's guidelines. Normal distribution and similar variance were observed for all values. Graphs are means þ/À S.D. Criteria for significance, routinely determined relative to wt aS: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Sufficient experiments and replicates were analyzed to achieve statistical significance and these judgements were based on earlier, similar work (23, 24) .
